Network pharmacology and in vivo study: Unraveling the therapeutic mechanisms of Panax ginseng in potentially treating ulcerative colitis

Figure 5 Panaxadiol attenuated intestinal inflammation in mice with dextran sulfate sodium-induced colitis. A: Representative images of hematoxylin-eosin staining (× 40 and × 200 magnification); B: Histopathological score; C and D: Panaxadiol treatment reduces pro-inflammatory cytokines (C) and pro-inflammatory mediators (D) in mice with dextran sulfate sodium-induced colitis. Data are expressed as mean ± standard error of the mean (n = 6). ^aP < 0.05; ^bP < 0.01; DSS: Dextran sulfate sodium; PD: Panaxadiol.